These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10354547)

  • 21. Antibodies and resistance to natural HIV infection.
    Nabel GJ; Sullivan NJ
    N Engl J Med; 2000 Oct; 343(17):1263-5. PubMed ID: 11071680
    [No Abstract]   [Full Text] [Related]  

  • 22. Modern vaccines. Human immunodeficiency virus and AIDS: challenges and progress.
    Schild GC; Minor PD
    Lancet; 1990 May; 335(8697):1081-4. PubMed ID: 1970381
    [No Abstract]   [Full Text] [Related]  

  • 23. What are the correlates of protection?
    Cohen J
    Science; 1993 May; 260(5112):1259. PubMed ID: 8493565
    [No Abstract]   [Full Text] [Related]  

  • 24. Changing paradigms for an HIV vaccine.
    Schultz AM
    Adv Exp Med Biol; 1996; 397():79-90. PubMed ID: 8718586
    [No Abstract]   [Full Text] [Related]  

  • 25. 1999: a time to re-evaluate AIDS vaccine strategies.
    Ruprecht RM; Hofmann-Lehmann R; Rasmussen RA; Vlasak J; Xu W
    J Hum Virol; 2000; 3(2):88-93. PubMed ID: 10850895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developments in preclinical AIDS vaccine efficacy models.
    Bogers WM; Cheng-Mayer C; Montelaro RC
    AIDS; 2000; 14 Suppl 3():S141-51. PubMed ID: 11086857
    [No Abstract]   [Full Text] [Related]  

  • 27. Humoral immunity to HIV, SIV, and SHIV.
    Haigwood NL; Zolla-Pazner S
    AIDS; 1998; 12 Suppl A():S121-32. PubMed ID: 9632993
    [No Abstract]   [Full Text] [Related]  

  • 28. Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS.
    Shearer GM; Pinto LA; Clerici M
    Immunol Today; 1999 Feb; 20(2):66-71. PubMed ID: 10098324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine.
    Kuwata T; Miura T; Hayami M
    Trends Microbiol; 2001 Oct; 9(10):475-80. PubMed ID: 11597447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine.
    Putkonen P; Walther L; Zhang YJ; Li SL; Nilsson C; Albert J; Biberfeld P; Thorstensson R; Biberfeld G
    Nat Med; 1995 Sep; 1(9):914-8. PubMed ID: 7585217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune correlates of protection from HIV infection and AIDS.
    Heeney JL; Bruck C; Goudsmit J; Montagnier L; Schultz A; Tyrrell D; Zolla-Pazner S
    Immunol Today; 1997 Jan; 18(1):4-8. PubMed ID: 9018965
    [No Abstract]   [Full Text] [Related]  

  • 32. Attenuated retrovirus vaccines and AIDS.
    Shearer GM; Lucey DR; Clerici M
    Science; 1995 Nov; 270(5239):1219; author reply 1220-2. PubMed ID: 7502053
    [No Abstract]   [Full Text] [Related]  

  • 33. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
    Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
    Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV: to vaccinate or not to vaccinate?
    Ada G; Blanden B; Mullbacher A
    Nature; 1992 Oct; 359(6396):572. PubMed ID: 1406988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surrogates of protection in repeated low-dose challenge experiments.
    Long DM; Hudgens MG; Wu CD
    Stat Med; 2015 May; 34(10):1747-60. PubMed ID: 25628249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunodeficiency viruses and nonhuman primate models of AIDS].
    Klots IN
    Vopr Virusol; 2009; 54(3):8-12. PubMed ID: 19537090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV/AIDS: vaccines and alternate strategies for treatment and prevention.
    Voronin Y; Phogat S
    Ann N Y Acad Sci; 2010 Sep; 1205 Suppl 1():E1-9. PubMed ID: 20860672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward an understanding of the correlates of protective immunity to HIV infection.
    Haynes BF; Pantaleo G; Fauci AS
    Science; 1996 Jan; 271(5247):324-8. PubMed ID: 8553066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challenge.
    Gabriel B; Fiebig U; Hohn O; Plesker R; Coulibaly C; Cichutek K; Mühlebach MD; Bannert N; Kurth R; Norley S
    Virology; 2016 Feb; 489():1-11. PubMed ID: 26685794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New gene-based approaches for an AIDS vaccine.
    Puaux AL; Michel ML
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):357-72. PubMed ID: 12818622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.